meta_pixel
Tapesearch Logo
Log in
The Commentary Magazine Podcast

The Biden Plan to Kill the Golden Goose

The Commentary Magazine Podcast

Commentary Magazine

News Commentary, News, Politics

4.65.1K Ratings

🗓️ 6 May 2021

⏱️ 56 minutes

🧾️ Download transcript

Summary

Joe Biden’s administration has inexplicably decided to abrogate the intellectual property rights of vaccine manufacturers to satisfy a fringe progressive demand. Why? And the New York Times has all but declared the pandemic behind us as vaccination rates in the U.S. crater. Source Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to the commentary magazine daily podcast today is Thursday, May 6, 2021.

0:28.8

I'm John Pothoritz, the editor of commentary magazine with me as always executive editor Abe

0:33.6

Greenwald, hi Abe.

0:35.4

Hi John.

0:37.2

Associate editor Noah Rothman, hi Noah.

0:39.6

Hi John.

0:40.6

And senior writer Christine Rosen, hi Christine.

0:44.0

Hi John.

0:47.7

So then we can say that one of the great medical miracles of all time was the development

0:54.2

of these three authorized vaccines, two of them using the same technology, Moderna and

1:02.6

Pfizer, mRNA technology, Johnson and Johnson using a different method.

1:08.3

There's also the AstraZeneca vaccine that seems to be on the on the I don't know with

1:14.1

the waiting room on the launch pad.

1:15.7

I don't know whatever analogy you want to give this all this all happened in unbelievably

1:21.0

record time. We have an amazing piece coming out in the magazine probably end of next week

1:26.0

by Jim Megs on how this happened and the speed with which it happened and the fact that

1:32.4

Moderna, the company that's one of the two vaccines literally came into existence in 2010

1:42.9

because it wanted to make use of mRNA technology or mRNA ideas that this was a new way to find

1:56.7

vaccines and cures and things.

1:59.8

It came into existence. It lost a lot of money. It had a big reversal in 2016 on a product

2:07.2

that it was trying to bring to market and that it was but it was all there ready and primed

2:11.9

in the minute that this came out and people knew about it. Moderna basically had the vaccine

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Commentary Magazine, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Commentary Magazine and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.